Welcome to our dedicated page for Semler Scientific SEC filings (Ticker: SMLR), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
QuantaFlo® device sales on one page, fair-value bitcoin gains on the next—Semler Scientific’s disclosures can feel like two different companies inside a single filing. Whether you are combing through a Semler Scientific quarterly earnings report 10-Q filing for unit volumes or hunting the note that explains recent crypto purchases, deciphering hundreds of pages is tough. This page delivers Semler Scientific SEC filings explained simply so you can stop scrolling and start understanding.
Stock Titan’s AI reads every submission the moment it hits EDGAR and turns it into plain-English answers. Need the footnote that reconciles BTC holdings? Our engine flags it. Curious about board incentives? The Semler Scientific proxy statement executive compensation section is highlighted automatically. Real-time alerts cover Semler Scientific Form 4 insider transactions real-time and summarize each trade, while one-click views join every Semler Scientific 8-K material events explained with context. Here’s what you’ll find:
- Semler Scientific annual report 10-K simplified—AI extracts QuantaFlo revenue, R&D spend and bitcoin valuation swings.
- Instant dashboards for Semler Scientific insider trading Form 4 transactions and executive buying patterns.
- Concise tables that power Semler Scientific earnings report filing analysis across sequential quarters.
- Full text search, tagging and export for auditing or modelling.
Professionals use these insights to monitor reimbursement risk, gauge PAD market penetration, or track digital-asset strategy without reading each footnote. Whether you’re understanding Semler Scientific SEC documents with AI, reviewing Semler Scientific executive stock transactions Form 4, or studying supply-chain commentary, Stock Titan keeps you ahead of the next disclosure—no manual parsing required.
Semler Scientific and Strive share a long-form discussion outlining Strive’s Bitcoin-focused treasury model and its proposed business combination with Semler Scientific. Strive’s CIO describes using Bitcoin as a core balance-sheet asset, targeting long-term compounding in response to perceived monetary debasement and liquidity cycles.
The talk highlights Strive’s choice to avoid restrictive convertible debt, instead raising about $750 million of equity via a PIPE plus $750 million of traditional warrants, and later issuing a $200 million perpetual preferred stock called SATA with a stated 12% dividend. Management says Strive holds over 7,500 Bitcoin and that acquiring Semler could add more than 5,000 additional Bitcoin. They emphasize a simple capital structure with no debt, only common equity and perpetual preferred, and frame SATA as “digital credit” designed for yield-focused investors while common stock targets those seeking amplified Bitcoin exposure.
Strive, Inc. released a communication about its proposed business combination with Semler Scientific, Inc., focusing on legal and procedural information rather than deal terms. It explains that many statements about the transaction and the future performance of the combined company are forward-looking and subject to significant risks and uncertainties, referring investors to recent Form 10-Q filings and Strive’s Form S-4 for more detail. Strive has filed a Registration Statement on Form S-4 to register Class A common stock to be issued in the transaction, which includes an information statement for Strive, a proxy statement for Semler Scientific and a prospectus for Strive. Semler Scientific stockholders will receive a definitive Information Statement/Proxy Statement/Prospectus to vote on the transaction, and investors are directed to obtain SEC filings for complete information. The communication also clarifies that it is not an offer to sell securities or a solicitation of any vote or purchase.
Semler Scientific CEO Douglas Murphy-Chutorian reported stock option activity and share sales. On 11/17/2025 he exercised a stock option to acquire 125,000 shares of Semler Scientific common stock at an exercise price of $2.23 per share. He then sold 57,669 shares at a weighted average price of $20.09 and 12,737 shares at a weighted average price of $20.73, with the filing stating that these sales were made to cover the option exercise price and withholding taxes. The filing also shows a transfer of 54,594 shares from direct ownership to a family trust and a corresponding 54,594-share increase in indirect ownership. After these transactions, Murphy-Chutorian reports beneficial ownership of 241,303 shares held indirectly through a family trust over which he and his spouse share voting and investment power.
Strive, Inc. released a Rule 425 communication regarding its proposed business combination with Semler Scientific. The message, posted by Strive’s CEO on X, reiterates cautionary forward‑looking statements.
Strive has filed a Registration Statement on Form S-4 to register the Class A common stock to be issued in connection with the transaction. A definitive Information Statement/Proxy Statement/Prospectus will be sent to Semler Scientific stockholders to seek their approval. Investors are urged to read these materials when available on the SEC’s website. The communication also states it is not an offer to sell or solicit the purchase of securities.
Strive, Inc. reposted a communication on X from board member Pierre Rochard regarding its proposed business combination with Semler Scientific (SMLR). The notice reiterates forward‑looking statement cautions and points investors to SEC filings for details.
Strive has filed a Form S-4 to register Class A common stock to be issued in connection with the transaction, which will include an information statement of Strive, a proxy statement of Semler Scientific, and a prospectus of Strive. A definitive Information Statement/Proxy Statement/Prospectus will be sent to Semler Scientific stockholders to seek their approval. The communication also outlines where to access the S-4, related amendments, and future materials, and clarifies that this is not an offer to sell or solicit securities.
Strive, Inc. released a communication under Rule 425 about its proposed business combination with Semler Scientific, Inc. (SMLR). The message includes a broad forward‑looking statements disclaimer highlighting uncertainties around timing, integration and expected strategic and financial benefits.
Strive has filed a Registration Statement on Form S‑4 that will include an information statement of Strive, a proxy statement of Semler Scientific and a prospectus of Strive. Semler Scientific stockholders will receive a definitive document to vote on the transaction, and investors are urged to read the Registration Statement and related materials when available on the SEC’s website. The communication also states it is not an offer or solicitation to sell securities.
Strive, Inc. issued a Rule 425 communication about its proposed business combination with Semler Scientific, Inc. (SMLR). Strive has filed a Form S-4 to register Class A common stock to be issued in the transaction, which will include an information statement for Strive, a proxy statement for Semler Scientific, and a prospectus for Strive.
A definitive Information Statement/Proxy Statement/Prospectus will be sent to Semler Scientific stockholders to seek their approval. The companies emphasize forward-looking statement cautions, outline where investors can access SEC filings, note that directors and officers may be participants in the proxy solicitation, and clarify that this communication is not an offer or solicitation.
Strive, Inc. reposted on X a communication about its proposed business combination with Semler Scientific (SMLR). The message includes a forward‑looking statements caution and notes that Strive has filed a Form S‑4 to register Class A common stock to be issued in the transaction.
A definitive Information Statement/Proxy Statement/Prospectus will be sent to Semler stockholders to seek their approval, and investors are urged to read these materials when available. Documents will be accessible free of charge on the SEC’s website and via company investor relations pages. The communication also states it is not an offer or solicitation to buy or sell securities.
Strive, Inc. filed a Rule 425 communication regarding its proposed business combination with Semler Scientific (SMLR), noting that CEO Matthew Cole reposted the communication on X.com on November 12, 2025.
Strive has filed a Form S-4 registration statement to register Class A common stock to be issued in connection with the transaction. The S-4 will include an information statement/proxy statement/prospectus, and a definitive version will be sent to Semler stockholders to seek approval of the proposed transaction.
The notice includes extensive forward‑looking statement disclaimers and directs investors to read the S-4 and related materials when available, which will be accessible free of charge on the SEC’s website and the companies’ investor sites.
Semler Scientific (SMLR) announced a Bitcoin information dashboard on its website as a Regulation FD disclosure channel, providing broad, non‑exclusionary updates on its Bitcoin holdings, market data, and KPIs such as BTC Yield, BTC Gain, and BTC $ Gain. The company states that some information posted there may be material.
Semler reported BTC Yield of 0.9% for the third quarter of 2025 and 30.6% year‑to‑date through November 10, 2025, a KPI used to assess its strategy of acquiring Bitcoin, including when funded by issuing common stock or convertible instruments. The information in Item 7.01 is furnished, not filed.
FAQ
What is the current stock price of Semler Scientific (SMLR)?
What is the market cap of Semler Scientific (SMLR)?
